With a market capitalization (market cap) of $19.18B — a measure of how much the company is worth — Zimmer Biomet Holdings, Inc. is the 634th most valuable company in Healthcare as of August 18, 2026. Shares trade at $99.15, up +0.97% on the day.
of 2,587
price ÷ annual EPS
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Visit websiteAs of August 18, 2026, Zimmer Biomet Holdings, Inc. (ZBH) is worth $19.18B — this is its market capitalization, the total value of all its outstanding shares.
Zimmer Biomet Holdings, Inc.’s market cap is $19.18B, which ranks it #634 among the most valuable companies in the Healthcare sector tracked on MarketCapLens.
Zimmer Biomet Holdings, Inc. (ZBH) shares trade at $99.15, up 0.97% on the day, as of August 18, 2026.
Fundamentals are annual. Figures labeled with their fiscal year.
FY 2025
Zimmer Biomet Holdings, Inc. trades at a price-to-earnings (P/E) ratio of 27.9, based on its latest share price and annual earnings per share.